Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).

Bilici A., Ölmez Ö. F., Sezer A., Öksüzoğlu B., Kaplan M., Karadurmuş N., ...More

ASCO 2022, Illinois, United States Of America, 3 - 07 June 2022, pp.105, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1200/jco.2022.40.16_suppl.e12610
  • City: Illinois
  • Country: United States Of America
  • Page Numbers: pp.105
  • Akdeniz University Affiliated: Yes